Press release
Eliquis Market Growth Driven by Anticoagulant Therapy Demand and Cardiovascular Disease Burden, 2025-2032 | Pfizer Inc., Bristol-Myers Squibb Company
The qualitative latest Research report (2025-2032) on the Eliquis Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/8193
Focused on growth and future opportunities, this report is a go-to resource for industry leaders, investors, and decision-makers. With visuals, charts, and data-driven insights, the Eliquis Market has experienced rapid growth fueled by rising demand and innovation. This analysis gives you the competitive edge with actionable strategies backed by real data.
Industry Insights and Scope of the Eliquis Market
This report provides a comprehensive segmentation of the Eliquis Market scope, covering product types, applications, end-user markets, key regions, and leading competitors. It offers expert insights into current market conditions, historical performance, production trends, and revenue forecasts.
The financial performance of key players is assessed, including gross profits, sales volumes, and manufacturing costs. Analytical tools like SWOT analysis and Porter's Five Forces are used to evaluate market dynamics. Additionally, the report includes a detailed review of major players, covering their financials, product benchmarking, and competitive strategies.
Top Companies Covered In This Eliquis Market Report:
Pfizer Inc. and Bristol-Myers Squibb Company
The Eliquis Market Insights is projected to experience substantial growth during the forecast period from 2025 to 2032. In 2025, the market is expected to expand steadily, with major players increasingly adopting strategic initiatives to drive growth beyond initial forecasts. The competitive analysis highlights key industry players, their innovations, and business strategies. Additionally, the report identifies the most promising long-term growth opportunities and explores the latest advancements in processes and product development.
Buy the Complete Report with an Impressive Discount (Up to 25% Off) at: https://www.coherentmarketinsights.com/insight/buy-now/8193
Comprehensive segmentation and classification of the report:
By Indication: Reduction of Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation , Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery , Deep Vein Thrombosis , Pulmonary Embolism , Reduction in the Risk of Recurrence of Deep Vein Thrombosis and Pulmonary Embolism , Venous Thromboembolism (VTE) and Reduction in the Risk of Recurrent VTE in Pediatric Patients
By Strength: 2.5 mg and 5 mg
By Age Group: Pediatric and Adult
By Dosage Form: Oral Tablet and Oral Suspension
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
Geographical Landscape of the Eliquis Market:
◘ North America (U.S., Canada, Mexico)
◘ Europe (Germany, U.K., France, Russia, Italy, Spain)
◘ Asia-Pacific (China, India, Japan, Australia, Singapore, NZ)
◘ South America (Argentina, Brazil)
◘ Middle East & Africa (Saudi Arabia, Turkey, UAE, Africa)
Report Drivers and Trends Analysis:
The report also discusses the factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. Also highlighted in this report are growth factors, developments, trends, challenges, limitations, and growth opportunities. This section highlights emerging Eliquis Market trends and changing dynamics. Furthermore, the study provides a forward-looking perspective on various factors that are expected to boost the market's overall growth.
✅ Key Benefits:
✦ Quantitative analysis of market segments, trends, estimations, and dynamics (2025-2032).
✦ Insights into key drivers, restraints, and opportunities.
✦ Porter's Five Forces analysis for strategic decision-making.
✦ Segmentation analysis to identify market opportunities.
✦ Revenue mapping of major countries by region.
✦ Benchmarking and positioning of market players.
✦ Analysis of regional and global trends, key players, and growth strategies.
Why You Should Buy This Report:
■ The impact of technological advancements and emerging industry trends
■ Regulatory and policy shifts and their implications for stakeholders
■ Competitive landscape analysis, including key player profiles and growth strategies
■ Major market challenges like supply chain issues and evolving consumer behavior
■ Opportunities in new products, applications, and potential investment areas
This report delivers actionable insights via secondary research, direct stakeholder interviews, and expert validation through Coherent Market Insights' extensive regional database.
📌 Get Instant Access! Purchase Research Report and Receive a 25% Discount with limited-time offer: https://www.coherentmarketinsights.com/insight/buy-now/8193
💬 FAQ's
Q.1 What are the main factors influencing the Eliquis Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market's opportunities, risks, and general structure?
Q.4 Which of the top Eliquis Market companies compare in terms of sales, revenue, and prices?
Q.5 How are market types and applications and deals, revenue, and value explored?
Q.6 What does a business area's assessment of agreements, income, and value implicate?
✍️ PR Authored By:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report.
About Us:
With a proven excellence in market research, Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
☎️ Contact Us:
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-8-7924-7805
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eliquis Market Growth Driven by Anticoagulant Therapy Demand and Cardiovascular Disease Burden, 2025-2032 | Pfizer Inc., Bristol-Myers Squibb Company here
News-ID: 4145057 • Views: …
More Releases from Coherent Market Insights

Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb …
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth…

Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion …
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business…

Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by …
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…

Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni …
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…
More Releases for Eliquis
Eliquis Market Size and Share: 2025 Analysis of Rising Business Opportunities wi …
The Eliquis market is witnessing significant industry momentum driven by increasing prevalence of cardiovascular disorders and a growing emphasis on anticoagulant therapies worldwide. Innovations in drug delivery and expanded clinical indications have further amplified the market scope, positioning Eliquis as a pivotal player in managing thromboembolic events. The Global Eliquis Market size is estimated to be valued at USD 7.2 billion in 2025 and is expected to reach USD 10.3…
Eliquis Market Thrives with Rising Incidence of Atrial Fibrillation and Stroke P …
The Eliquis market is a critical segment within the anticoagulant therapy domain, witnessing significant advancements due to its expanding application for stroke prevention in atrial fibrillation and treatment of venous thromboembolism. Increasing prevalence of cardiovascular disorders globally has propelled industry share and stimulated product demand across multiple healthcare segments. The Global Eliquis Market size is estimated to be valued at USD 7.90 billion in 2025 and is expected to reach…
Apixaban (Eliquis) Manufacturing Plant Project Report 2025: Key Insights and Bus …
Introduction
The pharmaceutical sector has consistently been at the forefront of healthcare innovation, developing life-saving medications that cater to diverse medical needs. One such medication is Apixaban (Eliquis), an oral anticoagulant (blood thinner) that has revolutionized the management of conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Manufactured by Bristol-Myers Squibb and Pfizer, Apixaban is used to reduce the risk of stroke and blood clots. Establishing a manufacturing plant…
Eliquis Market Latest Technology, Emerging Technology, Historical Demands by Reg …
In 2024, the Wiseguy Reports latest published research report on "Eliquis market growth is growing steadily with exponential rate and a rising adoption of strategies by top industry players, over the projected horizon 2024 to 2032".
Eliquis Market share was valued at 13.73 Billion US$ in 2023. The Eliquis Market Industry is expected to grow from 15.32 Billion US$ in 2024 to 36.87 Billion US$ by 2032. The Eliquis…
Eliquis Market Trends, Market Share, Industry Size, Growth, Opportunities and Ma …
The global eliquis market is anticipated to grow at a significant CAGR of 4.8% during the forecast period (2022-2028). Eliquis (apixaban) is a prescription pharmaceutical used to lower the risk of stroke and blood clots in patients with a trial fibrillation, additionally; it lowers the risk of blood clots formation in the legs and lungs of persons who have recently had hip or knee replacement surgery. Apixaban is an anticoagulant…
Apixaban Market is Booming 2019 | Pfizer, Roche, CoaguSense, Siemens, Alere, Abb …
Apixaban is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The recommended dose of Eliquis is 5mg orally twice a day. Apixaban is available in the market as capsules and tablet form.
Increasing prevalence of venous thromboembolism related conditions is expected to aid in growth of the apixaban market. For instance, according to International Society on Thrombosis and Haemostasis 2014 facts, revealed that…